Literature DB >> 16363813

Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.

Rinku Majumder1, Gabriel Weinreb, Barry R Lentz.   

Abstract

Activation of prothrombin to thrombin is catalyzed by a "prothrombinase" complex, traditionally viewed as factor X(a) (FX(a)) in complex with factor V(a) (FV(a)) on a phosphatidylserine (PS)-containing membrane surface, which is widely regarded as required for efficient activation. Activation involves cleavage of two peptide bonds and proceeds via one of two released intermediates or through "channeling" (activation without the release of an intermediate). We ask here whether the PS molecule itself and not the membrane surface is sufficient to produce the fully active human "prothrombinase" complex in solution. Both FX(a) and FV(a) bind soluble dicaproyl-phosphatidylserine (C6PS). In the presence of sufficient C6PS to saturate both FX(a) and FV(a2) (light isoform of FV(a)), these proteins form a tight (Kd = 0.6 +/- 0.09 nM at 37 degrees C) soluble complex. Complex assembly occurs well below the critical micelle concentration of C6PS, as established in the presence of the proteins by quasi-elastic light scattering and pyrene fluorescence. Ferguson analysis of native gels shows that the complex migrates with an apparent molecular mass only slightly larger than that expected for one FX(a) and one FV(a2), further ruling out complex assembly on C6PS micelles. Human prothrombin activation by this complex occurs at nearly the same overall rate (2.2 x 10(8) M(-1) s(-1)) and via the same reaction pathway (50-60% channeling, with the rest via the meizothrombin intermediate) as the activation catalyzed by a complex assembled on PS-containing membranes (4.4 x 10(8) M(-1) s(-1)). These results question the accepted role of PS membranes as providing "dimensionality reduction" and favor a regulatory role for platelet-membrane-exposed PS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16363813     DOI: 10.1021/bi051469f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Functional and structural characterization of factor Xa dimer in solution.

Authors:  Rima Chattopadhyay; Roxana Iacob; Shalmali Sen; Rinku Majumder; Kenneth B Tomer; Barry R Lentz
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

2.  Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

Authors:  Mettine H A Bos; Michael Boltz; Liam St Pierre; Paul P Masci; John de Jersey; Martin F Lavin; Rodney M Camire
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

3.  Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation.

Authors:  Tilen Koklic; Rinku Majumder; Barry R Lentz
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

Review 4.  Traumatic brain injury-associated coagulopathy.

Authors:  Jianning Zhang; Rongcai Jiang; Li Liu; Timothy Watkins; Fangyi Zhang; Jing-fei Dong
Journal:  J Neurotrauma       Date:  2012-10-31       Impact factor: 5.269

5.  Modulation of prothrombinase assembly and activity by phosphatidylethanolamine.

Authors:  Rinku Majumder; Xiaoe Liang; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

6.  Phosphatidylserine and FVa regulate FXa structure.

Authors:  Kinshuk Raj Srivasatava; Rinku Majumder; William H Kane; Mary Ann Quinn-Allen; Barry R Lentz
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

7.  A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.

Authors:  Rinku Majumder; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  Blood       Date:  2008-06-27       Impact factor: 22.113

8.  Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.

Authors:  Rinku Majumder; Tilen Koklic; Alireza R Rezaie; Barry R Lentz
Journal:  Biochemistry       Date:  2012-12-27       Impact factor: 3.162

9.  Factor XA binding to phosphatidylserine-containing membranes produces an inactive membrane-bound dimer.

Authors:  Tilen Koklic; Rinku Majumder; Gabriel E Weinreb; Barry R Lentz
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

10.  Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.

Authors:  William E Plautz; Vijaya Satish Sekhar Pilli; Brian C Cooley; Rima Chattopadhyay; Pamela R Westmark; Todd Getz; David Paul; Wolfgang Bergmeier; John P Sheehan; Rinku Majumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-01       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.